202 related articles for article (PubMed ID: 10327057)
1. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.
Bartsch D; Hahn SA; Danichevski KD; Ramaswamy A; Bastian D; Galehdari H; Barth P; Schmiegel W; Simon B; Rothmund M
Oncogene; 1999 Apr; 18(14):2367-71. PubMed ID: 10327057
[TBL] [Abstract][Full Text] [Related]
2. [Alterations in DPC4 gene in pancreatic cancers].
Gu L; Chen J; Cui Q
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):293-5. PubMed ID: 11783110
[TBL] [Abstract][Full Text] [Related]
3. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
4. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
5. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
8. DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors.
Perren A; Saremaslani P; Schmid S; Bonvin C; Locher T; Roth J; Heitz PU; Komminoth P
Diagn Mol Pathol; 2003 Dec; 12(4):181-6. PubMed ID: 14639103
[TBL] [Abstract][Full Text] [Related]
9. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
10. DPC4 gene in various tumor types.
Schutte M; Hruban RH; Hedrick L; Cho KR; Nadasdy GM; Weinstein CL; Bova GS; Isaacs WB; Cairns P; Nawroz H; Sidransky D; Casero RA; Meltzer PS; Hahn SA; Kern SE
Cancer Res; 1996 Jun; 56(11):2527-30. PubMed ID: 8653691
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
Zhuang Z; Vortmeyer AO; Pack S; Huang S; Pham TA; Wang C; Park WS; Agarwal SK; Debelenko LV; Kester M; Guru SC; Manickam P; Olufemi SE; Yu F; Heppner C; Crabtree JS; Skarulis MC; Venzon DJ; Emmert-Buck MR; Spiegel AM; Chandrasekharappa SC; Collins FS; Burns AL; Marx SJ; Lubensky IA
Cancer Res; 1997 Nov; 57(21):4682-6. PubMed ID: 9354421
[TBL] [Abstract][Full Text] [Related]
12. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
13. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
Bläker H; von Herbay A; Penzel R; Gross S; Otto HF
Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187
[TBL] [Abstract][Full Text] [Related]
14. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.
MacGrogan D; Pegram M; Slamon D; Bookstein R
Oncogene; 1997 Aug; 15(9):1111-4. PubMed ID: 9285566
[TBL] [Abstract][Full Text] [Related]
15. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressive pathways in pancreatic carcinoma.
Rozenblum E; Schutte M; Goggins M; Hahn SA; Panzer S; Zahurak M; Goodman SN; Sohn TA; Hruban RH; Yeo CJ; Kern SE
Cancer Res; 1997 May; 57(9):1731-4. PubMed ID: 9135016
[TBL] [Abstract][Full Text] [Related]
17. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
Hahn SA; Bartsch D; Schroers A; Galehdari H; Becker M; Ramaswamy A; Schwarte-Waldhoff I; Maschek H; Schmiegel W
Cancer Res; 1998 Mar; 58(6):1124-6. PubMed ID: 9515793
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation.
Muscarella P; Melvin WS; Fisher WE; Foor J; Ellison EC; Herman JG; Schirmer WJ; Hitchcock CL; DeYoung BR; Weghorst CM
Cancer Res; 1998 Jan; 58(2):237-40. PubMed ID: 9443399
[TBL] [Abstract][Full Text] [Related]
20. No SMAD4 hypermethylation in colorectal cancer.
Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
